Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Use and COVID-19: Time to Change Practice or Keep Gathering Data?

Clin Infect Dis. 2020 Dec 3;71(9):2457-2458. doi: 10.1093/cid/ciaa819.
No abstract available

Keywords: ACEi/ARB; covid-19; hypertension; kidney injury; respiratory failure.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acute Kidney Injury*
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • COVID-19*
  • France
  • Humans
  • Pandemics
  • Referral and Consultation
  • SARS-CoV-2
  • Time

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors